RN7SL478P

Across TCGA pan-cancer cohorts, RN7SL478P RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated RN7SL478P data layer.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher RN7SL478P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RN7SL478P expression acts as an unfavorable survival marker.

LUSC, KIRC, and BRCA are the cancer types where RN7SL478P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUSC	OS	Tertile	All	0.226	0.418	<.001	93	view →
KIRC	OS	Tertile	All	0.514	0.659	.003	69	view →
BRCA	DFS	Tertile	All	0.140	1.000	.001	36	view →
ACC	OS	Tertile	All	0.160	0.637	.014	36	view →
MESO	OS	Tertile	II,III,IV	0.370	0.576	.015	36	view →
LIHC	DFS	Tertile	II,III,IV	0.094	0.470	.001	33	view →
SKCM	OS	Tertile	II,III,IV	0.085	0.369	.014	27	view →
UCEC	OS	Tertile	III,IV	0.729	0.843	.036	12	view →
STAD	OS	Quartile	II,III,IV	0.534	0.765	.012	6	view →
OV	OS	Tertile	All	0.773	0.853	.048	6	view →
THCA	DFS	Tertile	II,III,IV	0.750	0.936	.042	3	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

RN7SL478P–LUSC (OS)

Open the LUSC breakdown →